281 related articles for article (PubMed ID: 25656857)
1. [Systemic treatment of brain metastases from lung cancer].
Barlesi F; Spano JP; Cortot AB; Carpentier AF; Robinet G; Besse B
Cancer Radiother; 2015 Feb; 19(1):43-7. PubMed ID: 25656857
[TBL] [Abstract][Full Text] [Related]
2. Management of CNS disease in ALK-positive non-small cell lung cancer: Is whole brain radiotherapy still needed?
Wrona A
Cancer Radiother; 2019 Sep; 23(5):432-438. PubMed ID: 31331844
[TBL] [Abstract][Full Text] [Related]
3. Multimodality management of non-small cell lung cancer patients with brain metastases.
Ricciardi S; de Marinis F
Curr Opin Oncol; 2010 Mar; 22(2):86-93. PubMed ID: 20009927
[TBL] [Abstract][Full Text] [Related]
4. [Treatment for brain metastases of lung cancer].
Ueoka H
Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():426-31. PubMed ID: 9369918
[TBL] [Abstract][Full Text] [Related]
5. Brain metastases in non-small-cell lung cancer.
Dawe DE; Greenspoon JN; Ellis PM
Clin Lung Cancer; 2014 Jul; 15(4):249-57. PubMed ID: 24954227
[TBL] [Abstract][Full Text] [Related]
6. Management of brain metastases in non-small cell lung cancer in the era of tyrosine kinase inhibitors.
Wrona A; Dziadziuszko R; Jassem J
Cancer Treat Rev; 2018 Dec; 71():59-67. PubMed ID: 30366200
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer metastatic to the brain.
Jamal-Hanjani M; Spicer J
Clin Cancer Res; 2012 Feb; 18(4):938-44. PubMed ID: 22167408
[TBL] [Abstract][Full Text] [Related]
8. Treatment of brain metastases from lung cancer: chemotherapy.
Schuette W
Lung Cancer; 2004 Aug; 45 Suppl 2():S253-7. PubMed ID: 15552807
[TBL] [Abstract][Full Text] [Related]
9. Paradigm shift of therapeutic management of brain metastases in EGFR-mutant non-small cell lung cancer in the era of targeted therapy.
Sekine A; Satoh H
Med Oncol; 2017 Jul; 34(7):121. PubMed ID: 28555261
[TBL] [Abstract][Full Text] [Related]
10. [Management of brain metastases for lung cancer patients].
Barlesi F; Khobta N; Tallet A; Goncalves A; Azria D; Spano JP; Carpentier AF; Régis J; Metellus P
Bull Cancer; 2013 Mar; 100(3):303-8. PubMed ID: 23518334
[TBL] [Abstract][Full Text] [Related]
11. Brain metastases in lung cancer.
Gaspar LE
Expert Rev Anticancer Ther; 2004 Apr; 4(2):259-70. PubMed ID: 15056056
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced non-small-cell lung cancer with epidermal growth factor receptor (EGFR) mutation or ALK gene rearrangement: results of an international expert panel meeting of the Italian Association of Thoracic Oncology.
Gridelli C; de Marinis F; Cappuzzo F; Di Maio M; Hirsch FR; Mok T; Morgillo F; Rosell R; Spigel DR; Yang JC; Ciardiello F
Clin Lung Cancer; 2014 May; 15(3):173-81. PubMed ID: 24486058
[TBL] [Abstract][Full Text] [Related]
13. Systemic therapy for lung cancer brain metastases: a rationale for clinical trials.
Oh Y; Stewart DJ
Oncology (Williston Park); 2008 Feb; 22(2):168-78; discussion 178, 183, 188 passim. PubMed ID: 18409662
[TBL] [Abstract][Full Text] [Related]
14. Improving Treatment Options for Brain Metastases From ALK-Positive Non-Small-Cell Lung Cancer.
Wardak Z; Choy H
J Clin Oncol; 2016 Dec; 34(34):4064-4065. PubMed ID: 27863198
[No Abstract] [Full Text] [Related]
15. Gefitinib and erlotinib for non-small cell lung cancer patients who fail to respond to radiotherapy for brain metastases.
Song Z; Zhang Y
J Clin Neurosci; 2014 Apr; 21(4):591-5. PubMed ID: 24256883
[TBL] [Abstract][Full Text] [Related]
16. Medical treatment of brain metastases from lung cancer.
Cappuzzo F
Suppl Tumori; 2002; 1(4):S58-9. PubMed ID: 12415823
[No Abstract] [Full Text] [Related]
17. [ANOCEF guidelines for the management of brain metastases].
Le Rhun É; Dhermain F; Noël G; Reyns N; Carpentier A; Mandonnet E; Taillibert S; Metellus P;
Cancer Radiother; 2015 Feb; 19(1):66-71. PubMed ID: 25666314
[TBL] [Abstract][Full Text] [Related]
18. Combined modality therapy of lung cancer.
Livingston RB
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2638-47. PubMed ID: 10068267
[TBL] [Abstract][Full Text] [Related]
19. Targeted Therapy as an Alternative to Whole-Brain Radiotherapy in EGFR-Mutant or ALK-Positive Non-Small-Cell Lung Cancer With Brain Metastases.
Martínez P; Mak RH; Oxnard GR
JAMA Oncol; 2017 Sep; 3(9):1274-1275. PubMed ID: 28520828
[TBL] [Abstract][Full Text] [Related]
20. Erlotinib in patients with previously irradiated, recurrent brain metastases from non-small cell lung cancer: two case reports.
von Pawel J; Wagner H; Duell T; Poellinger B
Onkologie; 2008 Mar; 31(3):123-6. PubMed ID: 18322416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
